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Abstract 
We investigated the effects of modifying a normal dietary fatty-acid composition and 
the ingestion of high-fat exercise supplements on gastrointestinal distress, substrate 
oxidation, and endurance cycling performance. Five female cyclists completed a 
randomized triple-crossover comprising a two-week diet high in octanoate-rich esterified 
oil (MCFA), or twice, long-chain fatty acids (LCFA). Following the diets subjects 
performed 3-h of cycling at 50% peak power followed by ten maximal sprints while 
ingesting either a) a carbohydrate (CHO)+MCFA-rich oil emulsion after the two-week 
MCFA-rich dietary condition (MC-MC, Intervention) and b) after one LCFA-rich dietary 
condition (LC-MC, Placebo), or c) CHO only following a second LCFA-rich diet (LC-
CHO, Control). Ingestion of the CHO+MCFA-rich oil emulsion during 3-h steady-state 
exercise substantially reduced endogenous-fat oxidation by 88% (90% CI: 59–117%) and 
74% (40–108%) in the MC-MC and LC-MC conditions, respectively, relative to LC-CHO, 
but there was no effect of MCFA adaptation. Adaptation (MC-MC) also had no clear effect 
on endogenous CHO (11%, -10–33%) or exogenous octanoic-acid oxidation rates (-2%, -
20–16%), relative to the placebo (LC-MC). Ingestion/oxidation efficiency of octanoic acid 
was high (0.98), but the CHO+MCFA-rich oil emulsion caused mild-moderate 
gastrointestinal distress during exercise and there was no attenuating effect of MCFA 
adaptation evident, nor any clear benefit of the oil emulsion or adaptation to performance. 
Plasma triacylglycerol concentrations were lower by 17% (23– -4%) and 15% (20– -3%; 
reduction likely) in the LC-MC and MC-MC conditions, respectively, relative to LC-CHO. 
Total plasma free-fatty acid concentrations were 20% lower (39–3%) in the LC-MC 
condition, relative to LC-CHO. Plasma glycerol concentrations trended lower in the LC-
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MC and MC-MC conditions, but uncertainty meant these effects were qualified unclear. 
There was no clear effect of MCFA adaptation on total and 13C-enriched plasma octanoic-
acid concentrations, nor were there any detectable elongation products (13C-enriched fatty 
acids >8:0) seen in the plasma in either the MC-MC or LC-MC conditions To conclude, 
despite high efficiency of exogenous-MCFA oxidation, no clear benefit to prolonged-
endurance performance was observed with the ingestion of a CHO+MCFA-rich esterified 
oil emulsion or following adaptation to a MCFA-rich diet in female cyclists. 
 
Key words: medium-chain fatty acids, structured triacylglycerols, dietary adaptation, 
supplementation 
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Introduction 
The finite availability of endogenous glycogen as an energy substrate contributes to the 
development of fatigue, and is therefore a limiting factor in athletic performance during 
prolonged strenuous exercise (Kiens and Helge 1998). An increase in plasma free fatty acid 
(FFA) and fat oxidation has been shown to spare endogenous glycogen, most reliably via 
fat infusion studies (Vukovich, Costill et al. 1993). However, fat infusion during racing 
conditions is not feasible and long chain triglyceride ingestion before or during exercise has 
not been shown to enhance performance (Rowlands and Hopkins 2002). More recently, 
interest has focused on the ingestion of medium-chain triglycerides (MCTs). Medium-chain 
fatty acids (MCFA) can be absorbed more rapidly and directly from the intestinal lumen, 
and their entry into mitochondria does not appear to be rate-limited by the acyl-carnitine 
transfer system to the extent of long chain fatty acids (LCFA) during high-intensity 
exercise (Greenberger, Rodgers et al. 1966; Sidossis, Gastaldelli et al. 1997). Therefore, 
ingestion of MCFAs during exercise has the potential to enhance performance by elevating 
plasma FFA concentrations and sparing muscle glycogen (Van Zyl, Lambert et al. 1996; 
VanZyl, Lambert et al. 1996; Vistisen, Nybo et al. 2003). 
Previously, studies have focused on the effects of ingesting MCFA-rich exercise 
supplements on performance in males only. In trials feeding 25-30 g MCT suspensions, the 
oxidation of MCFA reached 30% of the ingested quantity compared with 70% oxidation 
when co-ingested with carbohydrate (CHO). Plasma FFA and ketone concentrations were 
elevated, but no overall change in total lipid or CHO oxidation was observed (Jeukendrup, 
Saris et al. 1995; Jeukendrup, Saris et al. 1996). In contrast, 86 g MCT co-ingested with 
CHO has resulted in elevation of serum FFA concentration, reduced reliance on 
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endogenous CHO, and performance enhancement (2.5% decrease in 40-km time-trial time) 
relative to CHO-only ingestion with no reports of gastrointestinal distress (Vistisen, Nybo 
et al. 2003). Conversely, Jeukendrup et al. (1998) and Goedecke et al. (2005); (1999) did 
not observe performance benefits when feeding up to 85 g of MCT co-ingested with CHO 
during endurance and ultra-endurance exercise, which was related to the development of 
moderate-to-severe gastrointestinal distress. Additionally, no clear differences between fat 
and CHO oxidation with or without MCT ingestion were observed in these later studies. 
Chronic dietary MCT adaptation (Misell, Lagomarcino et al. 2001; Misell, 
Lagomarcino et al. 2001; Oopik, Timpmann et al. 2001) and ingestion of structured 
triacylglycerols (Vistisen, Nybo et al. 2003) have been investigated as ways to attenuate 
gastric distress when ingesting MCTs during exercise. Though gastric distress was 
alleviated in these studies, no performance benefit was observed when ingesting MCFA 
supplements during exercise. We recently investigated whether combining a dietary 
adaptation period (2-weeks) plus ingestion of a structured triacylglycerol (randomized-
structured MCFA oil+CHO) emulsion during exercise would further attenuate gastric 
distress, and thereby allow a performance benefit to show through due to greater 
exogenous-energy supply (Thorburn, Vistisen et al. 2006). Gastric distress in response to 
the MCFA-rich exercise supplement was attenuated during the performance test following 
the 2-week MCFA adaptation period. In addition, almost 3-fold greater (0.43 g⋅min-1) 
MCFA oxidation was observed in comparison to that previously reported (0.15 g⋅min-1) 
(Jeukendrup, Saris et al. 1996). However, sprint performance remained substantially 
impaired in comparison to CHO-only. 
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The aim of the present study, therefore, was to investigate the effects of a 2-week 
MCFA-rich dietary adaptation period and ingestion of MCFA-rich exercise supplements on 
gastrointestinal distress, MCFA oxidation, and performance in a cohort of trained female 
cyclist. The majority, but not all, of well controlled studies have shown lower RER in 
females than males during submaximal endurance exercise (reviewed by (Tarnopolsky 
2000) indicating the possibility of proportionately higher fat oxidation. Therefore, females 
could potentially make better use of exogenous MCFA supplements than their male 
counterparts, which may translate into performance benefits. 
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Materials and Methods 
Subjects 
Five well-trained female cyclists 31 years (SD 3) and 65 kg (2) completed the study.  
Three additional subjects withdrew due to illness not related to the study interventions or to 
other commitments. All cyclists had been training for at least 8-10 h per week and riding 
competitively for at least 6 months. Mean VO2max and peak power output were 3.4 L·min-1 
(0.2) and 243 W (9) respectively. Before beginning experimentation, all subjects read the 
study information sheet, were informed of their rights, screened for precluding health 
conditions, and signed a consent form. The experimental protocol of this study was 
approved by the Massey University Ethics Committee (Protocol 03/143). 
General Design 
Cyclists participated in a randomized double-blind triple-crossover protocol in which 
three dietary conditions modifying the normal fatty-acid composition were completed over 
three consecutive 2-week experimental blocks (Figure 1). The conditions were: a) Placebo 
– 2-week diet containing long-chain fatty-acid rich oil with the intervention CHO+MCFA-
rich esterified oil emulsion ingested during exercise (LC-MC); b) Intervention – 2-week 
diet containing MCFA-rich esterified oil with the CHO+MCFA-rich oil emulsion ingested 
during exercise as above (MC-MC); c) Control – 2-week diet containing LCFA-rich oil 
with a CHO-only exercise supplement (LC-CHO). All subjects began an individualized 
standardized training regime two weeks before the baseline 3-h ride and performance test 
(Figure 1). The training was repeated for each subsequent 2-week dietary condition. The 
training protocol included three-to-five supervised and workload-standardized lab sessions 
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where they ingested 500 ml of the dietary supplement during exercise. On the morning of 
each test, subjects reported to the lab between 6-8 AM in a fasted state, and the parameters 
of the cycle ergometers were adjusted according to the subject’s own racing cycle angles.  
Menstrual cycle phase was not controlled. This decision was made because, although 
suggested, a substantial effect of menstrual cycle phase on carbohydrate and fat metabolism 
during exercise has not been clearly established (Kanaley, Boileau et al. 1992; Frankovich 
and Lebrun 2000). Additionally, non-control reduced time that subjects would have to 
commit to the study from 14 to 8 weeks, thereby increasing the chance of retention, 
reducing the drift in performance ability, and replicating the conditions employed with 
males in our lab (Thorburn, Vistisen et al. 2006).  
 
[Insert Figure 1 near here] 
 
Protocols 
Maximal Oxygen Uptake (VO2max) and Peak Power Output (PPO) were measured 
using a progressive exercise protocol on an electronically-braked cycle ergometer 
(VeloTron Racer Mate, Seattle, WA). After warm-up, the test started at a workload of 2 
W·kg-1 body mass. The first stage duration was 150 s, after which the load was increased by 
50 W, and then by 25 W for every subsequent 150-s stage. Exhaustion was defined as the 
time at which the cyclist could no longer maintain a pedal cadence of 50 RPM after 3 
warnings. Maximal oxygen uptake was measured on-line with a calibrated SensorMedics 
Vmax Spectra Series gas analyzer (SensorMedics Corp., Yorba Linda, CA, USA) and taken 
as the highest attained 20-s average oxygen uptake. PPO was defined as the last completed 
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work rate plus the fraction of time spent in the final non-completed work rate multiplied by 
the 25 W work rate increase. 
Familiarization. Approximately 1-week following the OV& 2max test, a shortened 
version of the performance test (see below) was performed as a procedural familiarization 
trial. Subjects cycled for 2-h at 50% PPO, and performed 6 maximal sprints interspersed 
with recovery periods at 40% PPO. An 8% CHO-based solution was ingested every 20-min 
and subjects practiced recording gastrointestinal distress and ratings of relative perceived 
exertion. 
Baseline Test. This test provided information on gastric responses to naïve exposure of 
the CHO+MCFA-rich esterified-oil emulsion supplement (see below), doubling as a full 
practice trial of the testing procedure and a ride to deplete endogenous-glycogen stores to 
lower background 13C enrichment. Subjects rode for 3-h at 50% PPO, primarily for 
assessment of physiological responses, but also as a long preload/depletion ride prior to the 
repeated-sprint performance test, which consisted of 10 maximal-effort sprints interspersed 
with recovery periods as described below. 
Immediately before the start of exercise, subjects ingested a double quantity of the 
CHO+MCFA-rich esterified oil supplement. Every 20-min throughout the 3-h steady-state 
ride, gastrointestinal distress and exertion ratings were recorded before ingesting the next 
supplement, the quantity of which was based on individual PPO calculated from a base 
reference of 220 ml·20 min-1 for a PPO of 400 W. Subjects ingested between 127-141 ml of 
supplement/20 min (254-282 ml double bolus). During the sprints, subjects ingested each 
drink supplement throughout the 20 min as they liked, and reported gastrointestinal distress 
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and exertion immediately after sprints 1, 4, 7 and 10. Heart rate was continuously recorded 
by radiotelemetry (S610i Heart Rate Monitor, Polar Electro Oy, Finland). 
13C Background Trial. A 3-h ride at 50% PPO was performed on day 11 of each 2-week 
supplementation block (Figure 1) to determine background breath 13C-enrichment required 
for later calculation of octanoic-acid oxidation. During the ride, subjects ingested the 
experimental drink supplement, containing all components except the esterified oil. Every 
20-min during the 3-h ride external respiratory-gas was collected for indirect calorimetry 
(Sensormedics) and 13C breath enrichment, the latter into 10-ml evacuated rubber-capped 
test tubes (Labco Ltd., High Wycombe, UK) from a 5-L mixing chamber. For all 
experiments, the Sensormedics mass flow sensor and gas analyzers were calibrated before 
testing and every hour during the 3-h exercise test. Following testing, the raw minute 
volume and gas fractions were adjusted if drift was greater than 3% following each hour of 
sampling. Drift between the initial and verification calibrations was assumed to be linear 
and the raw data were adjusted accordingly. 
3-h Ride. On day 14 of each 2-week block subjects repeated the protocol undertaken 
during the baseline exercise test (Figure 1). Upon reporting to the lab, subjects had a 20GA 
cannula inserted into the antecubital vein of their right forearm (Becton Dickinson Medical 
Pte Ltd, Singapore). A 2-way stop-cock valve (Becton Dickinson Medical Pte Ltd, 
Singapore) was connected to the cannula and a 15-ml blood sample was taken immediately 
and transferred into vaccutainers (Becton Dickinson & Co., Franklin Lakes, USA) 
containing lithium heparin (5 ml) and EDTA (10 ml). Triplicate breath samples were 
collected from the mixing chamber for resting breath 13C enrichment. Immediately before 
exercise began, subjects consumed a double bolus of drink supplement. Every 20-min 
during the 3-h ride data variables were collected in the order of exertion and gastrointestinal 
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distress scales, indirect calorimetry, 13C breath enrichment, and a blood sample. 
Immediately following data collection another bolus of supplement was ingested. Heart rate 
was continuously recorded. 
Performance Test. After completion of the 3-h ride, subjects dismounted their cycles 
and were allowed to toilet and stretch. Upon remounting their ergometers, subjects 
completed ten maximal sprints interspersed and beginning with a recovery interval at 40% 
PPO. The duration of the sprint (2-3 min) and recovery (5-6 min) periods were based on 
work done (kilocalories), determined by individual PPO (0.125 x PPO). Fixed linear 
workloads approximately equivalent to riding a 39 or 56 front chain ring and a 10-spocket 
21 to 11 tooth rear cluster were programmed into the Velotron software. A gear switch was 
positioned on the end of the right handlebar break hood to provide convenient changing of 
linear resistance. Cyclists self-selected cadence and gearing but were instructed to sprint as 
fast as possible until the required kilocalories were achieved. No verbal encouragement was 
provided to the subjects, the only information provided during the sprints was elapsed work 
completed (kilocalories) shown on the computer screen. Subjects were given a verbal count 
down in preparation for the start of each sprint and at 20, 10, 5 and 2 kilocalories to go in 
preparation for the end of each sprint. 
Supplement ingestion continued during the sprint procedure with the allocated quantity 
ingested ad libitum every 20 min. Immediately after sprints 1, 4, 7 and 10, exertion and 
gastrointestinal distress data were collected.  A final 10 ml blood sample was taken 
immediately upon completion of the final sprint. 
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Diet and Supplements 
Diet and Dietary Supplementation. Immediately following the baseline test subjects 
started their first 2-week diet condition. The diets consisted of food and drink supplements 
containing either the MCFA-rich (⅓ canola and ⅔ trioctanoin esterified oils) or LCFA 
(canola only) oils in prescribed meal and snack replacements. Both MCFA and LCFA diets 
were administered in the same way so as to blind the subjects to each condition. Foods and 
supplements were prepared on site by food technologists and catering services and included 
muffins, sports fudge bars, curries, bolognese and milk-like drinks. Each item was 
produced to provide 15 g of experimental oil (either LCFA or MCFA-rich) per serving and 
a fixed macronutrient composition: 15, 55, and 30 percent energy from protein, 
carbohydrate, and oil, respectively, so that fortnightly consumption of the supplements and 
other foods could be replicated. The amount of food and supplements ingested by each 
subject was determined by body mass, relative to a model 65-kg female cyclist ingesting 78 
g of the experimental oils per day. In practice, the quantity of randomized esterified oil 
ingested during the 2-week diet (intervention condition) was 81 g·d-1 (SD 6) (54 g MCFA·d-
1 SD 4). Subjects recorded all food ingested over the first two-week experimental block and 
replicated that daily pattern over the proceeding two blocks. In addition to eating the foods 
and supplements during the day, subjects were instructed to ingest the sports bars and milk-
like drinks during training sessions to facilitate exercise gastrointestinal adaptation. 
Subjects were also provided with extensive lists and instructed not to eat any foods 
naturally enriched in 13C (cane sugar and maize products) beginning immediately after the 
baseline test, but to otherwise maintain their normal diet. Instructing subjects in this way 
has been shown to be effective in reducing background 13C enrichment (Jeukendrup, Saris 
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et al. 1995; Jeukendrup, Saris et al. 1995; Jeukendrup, Saris et al. 1996). Subjects verbally 
reported adhering to the dietary interventions. Two subjects reported experiencing slight 
cases of diarrhea and belching while on the intervention (MC-MC) diet though none 
claimed to be aware of which condition they were on at the time.  Both the LCFA- and 
MCFA-rich diets were otherwise well tolerated. 
Exercise Supplements. Four different milk-like drinks and emulsions were formulated 
for use during exercise. The drinks were flavored identically for placebo purposes. The 
drink containing the CHO+MCFA-rich esterified oil was made in two forms: the 
supplement ingested during the baseline, LC-MC and MC-MC performance (sprints) tests 
contained 5.7% esterified oil, 2.6% wheat-derived dextrose and 5.6% maltodextrin, 1.5% 
sodium caseinate emulsifier, 0.08% salt, colors, chocolate and vanilla flavoring; an 
identical supplement was ingested during the 3-h ride in the MC-MC and LC-MC dietary 
conditions, but also contained 1-13C octanoic-acid tracer incorporated into the esterified oil. 
The third, placebo-control exercise drink used in the LC-CHO condition contained the 
same ingredients as above minus the esterified oil, and with addition of 4.0% milk powder 
to emulate color and taste. The fourth drink used during the three 13C background trials 
consisted of identical ingredients to the drink containing the MCFA-rich esterified oil 
minus the oil and 13C tracer. The mean quantities of MCFA-rich esterified oil emulsion 
ingested were 77 g (SD 3) (51 g MCFA SD 2) and 31 g (SD 1.2) (21 g MCFA, SD 0.8) 
during the 3-h ride and performance test, respectively. 
In producing the exercise supplements, the oil was first heated to 50°C. Dry ingredients 
were mixed with water, colors and flavors, and the two mixtures were then combined and 
homogenized to disperse the fat droplets (giving the drinks a milky appearance) and 
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refrigerated. The drinks were made 1-5 days before ingestion and had a minimum 
refrigerated shelf life of 10 days. 
Randomized-Esterified Oil 
A blended oil mixture consisting of ⅓ canola (LCT) and ⅔ trioctanoin oil was mixed in 
a batch reactor by an impeller at 230 rpm. After the vacuum reached 100 mbar, the oil was 
dried for 30 min at 90°C. Temperature was then decreased to 60°C and 0.1 wt% sodium 
methoxide was added while stirring. Any air in the reactor was removed using vacuum and 
N2 systems. After 30 min, the reaction was stopped by addition of a 5 wt% citric-acid water 
solution. The oil was washed 3-4 times until pH was below 7, and dried again before 
deodorization in a conventional batch deodorizer. Vacuum was adjusted to less than 5 
mbar, stripping steam consumption was adjusted to 4 wt%, and temperature was raised to 
160°C for 2 h. After deodorization, the oil was cooled by tap water circulation with N2 
protection, and stored in a -25°C freezer. 
1-13C-Octanoic Acid-Enriched Esterified Oil 
The 1-13C-octanoic acid-enriched esterified oil was produced by esterification of 13C-
labelled octanoic acid (C8:0) (Cambridge Isotope Laboratories, Andover, MA), oleic acid 
(18:1n-9) and glycerol in the proportion of 3:1:1.6. Components were mixed 10:1 with 
lipase (Novozym, Novozymes, Bagsvaerd, Denmark) at 60°C with constant stirring. 
Vacuum removed excess water from the process by passing the air through anhydrous 
Na2SO4 (JT Baker, Deventer, Holland). After a 24 h incubation period, the reaction was 
stopped by separating the oil and enzymes with filtering. The oil was then kept at -20°C 
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until use. The 13C-enriched oil was mixed into the randomized esterified oil that yielded a 
mean oil 13C-enrichment of 84 δ·mil-1 vs. PDB (SD 30) (0.006854 13C/12C ratio).  
Psychometric Scales    
Perceived exertion (soreness of legs and effort of cycling) and gastrointestinal distress 
(nausea, fullness/bloatedness, stomach cramp, reflux/burping) markers were measured 
using scales modeled from Borg’s CR10 scale (Borg et al. 1998). Verbal descriptors were 
associated with the scale: nothing 0, very weak 1, weak or mild 2, moderate 3, strong 5, 
very strong 7, extremely strong 10, and absolute maximum 13.5. Subjects were instructed 
to make a pen mark on a continuous scale, rating the strength of their exertion or distress. 
 
Analyses 
13C Enrichment. Breath samples were analyzed for 13C/12C by gas chromatography 
continuous flow isotope ratio mass spectrometry (Finnigan Delta XP, Bremen, Germany). 
The enrichment of the esterified oil was measured using Elemental Analyzer isotope ratio 
mass spectrometry. 
Calculations. Oxidation rates (g·min-1) of exogenous octanoic acid and total fat and 
CHO were calculated from 13C-enrichment and indirect calorimetry measurements. Isotopic 
enrichment of expired air was expressed as the delta per million difference (δ‰) between 
13C/12C ratio of the sample and a known laboratory reference standard (Pee Dee Belemnite; 
PDB) according to the formula: δ13C = [(13C/12C ratio sample/13C/12C ratio standard) – 
1]·103 ‰, where, 13C/12C standard = 0.0112372 (Craig 1957). The amount of octanoic-acid 
oxidized is then calculated according to the formula: Exogenous octanoic-acid oxidation 
(g·min-1) = VCO2·(δExp - δbkg/δIng - δbkg)·(1/k), in which δbkg is the 13C enrichment of expired 
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air in the 3-h background trial, δExp is the 13C enrichment of expired air during the 3-h ride 
with 13C-enriched esterified oil ingestion, δIng is the 13C enrichment of the oil in the 
ingested exercise supplement, and k is the amount of CO2 (liters) produced via oxidation of 
1 g octanoic acid on a glycerol backbone (k = 1.2369 L CO2·g trioctanoin-1) (Jeukendrup, 
Saris et al. 1995). A conversion factor of 34.19 kJ·g-1 was used to estimate MCFA 
contribution to energy expenditure (Livesey and Elia 1988). 
Total carbohydrate and fat-oxidation rates were calculated using the non-protein 
respiratory quotient (Jeukendrup and Wallis 2005): Carbohydrate oxidation (g·min-1) = 
4.210·VCO2 – 2.962·VO2, Fat oxidation (g·min-1) = 1.695·VO2 – 1.701·VCO2. Conversion 
factors of 15.64 kJ·g-1 (Ferrannini 1988) for CHO, and 40.81 kJ·g-1 (Péronnet and 
Massicotte 1991) for fat oxidation were used to estimate contribution to energy 
expenditure. The oxidation rate of other fats was the total fat-oxidation rate minus the 
octanoic acid oxidation rate. 
Calculation of exogenous substrate oxidation is affected by the delayed equilibration of 
13CO2 originating from the tissues with the large endogenous HCO3- pool. However, a 
physiological steady-state condition occurs relatively rapidly during exercise, and 13CO2 in 
the expired air will be equilibrated with the 13CO2/H13CO2 pool from around 60 min of 
exercise (Robert 1987). As a consequence, calculations on substrate oxidation were only 
reported from 60 to 180 min of exercise. 
Plasma. Blood was collected into lithium heparin and EDTA-containing tubes, 
immediately centrifuged at 2000 G for 12 min, aspirated into eppendorf tubes and snap-
frozen in liquid nitrogen before being stored in a -80°C freezer until analysis. Plasma 
lactate, glucose, potassium, and acid-base variables were analyzed using an automated 
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blood gas analyzer (Bayer Rapidlab 800 system, Bayer HealthCare LLC, Tarrytown, NY, 
U.S.A). Before analysis, a quality control test was run to evaluate the system for 
imprecision and inaccuracy. Two-point calibrations for all parameters were performed 
every 45-60 samples. One-point calibrations for all parameters were performed every 15-20 
samples. One-point calibrations for PCO2, glucose and lactate were performed every 3 
samples. 
Triacylglycerol and glycerol concentrations were determined by thin layer and gas 
chromatography as described previously (Vistisen, Nybo et al. 2003). Extraction of plasma 
fatty acid for the determination of fatty acid concentration and isotopic enrichment was 
performed according to Patterson and colleagues (Patterson, Zhao et al. 1999). Fatty acid 
concentration was measured by gas chromatography with FID (Autosystem XL; Perkin 
Elmer, Northwalk, CT, USA), using 9:0 and 17:0 as internal standards. Plasma fatty acid 
13C enrichment was measured by gas chromatography-combustion isotope ratio mass 
spectrometry (GC-C-IRMS, Hewlett Packard 5890, Finnigan GC combustion III, Finnigan 
Deltaplus; Finnigan MAT, Bremen, Germany) as described previously (Van Hall, Bulow et 
al. 2002). 8:0 enrichment was corrected by a factor of 9/8 to account for the extra methyl 
group of the methyl octanoate derivative. A standard sample (Nu-Chek Prep, Elysian, MN) 
with known composition and quantities of fatty acid methyl esters was run daily. This 
standard contained fatty acid methyl esters with chain length of C6 to C22, which ensured 
detection of all plasma fatty acid methyl esters within this range. Fatty acids were identified 
by retention times of the standard fatty acid methyl esters. 
Sprint Data. Mean power (J·s-1) for each interval was calculated from the inbuilt 
efficiency factor and J conversion factors in the Velotron software code: kcal·4.186 
·1000·0.25/t, where kcal is the energy (kilocalories) expended by the subject during the 
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sprint, 4.186 is the conversion factor from kilocalories to kilojoules, 0.25 is the efficiency 
factor of an exercising person, and t is the time it took the subject to complete the sprint in 
seconds.  
 
Statistics 
General Method. The effect of diet condition on the outcome variables was estimated 
with mixed modeling in the Statistical Analysis System (SAS9.1, SAS Institute, Cary, NC). 
Most dependent variables were analyzed after log transformation to reduce the effects of 
non-uniformity of error. For measures of performance, metabolism, and other dependent 
physiological variables, the effects of the diets were compared in a three-way model, 
whereas the analysis of psychometric variables also included the Baseline test responses. 
Quantitative mixed linear models were applied to the time-series data sets for the 3-h 
exercise and during the sprint procedure where sample time or sprint number were numeric 
effects. For all datasets treatment was a fixed effect and for the performance and 
psychometric analyses an order term was included. In all data sets, the random effects were 
subject and the interaction between subject and condition. The random variability 
associated with moving between sprints (fatigue) or progression along a time series was 
also included in the analysis for the relevant data sets. The within-cyclist standard deviation 
was estimated from the residual variance. A mechanisms analysis of the relationship 
between power output and nausea was conducted as described previously (Thorburn, 
Vistisen et al. 2006).  
Presentation of Data. Measures of centrality and spread for subject descriptive, raw 
stable isotope, and dietary variables are raw means and standard deviations (SD). Means 
derived from the analysis of log-transformed variables are back log-transformed least-
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squares, or adjusted, means. The associated spread around these least-squares mean is 
represented by percentage (geometric) standard deviations or factor standard deviations 
(SDf), implying ×/÷. For example, for a plasma-glucose concentration of 5 mmol·L-1 with a 
between-subject standard deviation of 20% (SDf 20), the typical variation is 5 × 1.20 to 5 ÷ 
1.20, or 6 to 4.16 mmol·L-1. Data in graphs and text are shown as least-squares means.  
Data are rounded to two significant digits or in some cases three where the first digit is “1”. 
Precision of the Estimate and Practical Inference. In keeping with recent trends in 
inferential statistics, e.g., (Curran-Everett and Benos 2004; Sterne and Smith 2001), we 
made quantitative inferences about population (true) effect by expressing uncertainty as 
90% confidence limits (CL) or interval (CI) and as probabilities that the true value 
represents a practically-important substantial change (beneficial or detrimental, increase or 
decrease) (Batterham and Hopkins 2006). The smallest substantive change in sprint power 
was 1.1% as previously (Thorburn, Vistisen et al. 2006), with females assumed to be 
similar (Paton and Hopkins 2005). The smallest standardized (Cohen) change (i.e. effect-
size statistic) in the mean for biochemical and psychometric variables was 0.20 times the 
between-subject SD for the value in the control group (LC-CHO condition) (Cohen 1988). 
Probabilities of a substantial benefit or detriment, increase or decrease were calculated for 
90% CL from the two-tailed Student t-distribution (Hopkins 2001) and inferred as follows: 
<1%, almost certainly not; 1–5%, very unlikely; 5–25%, unlikely; 25–75%, possible; 75–
95%, likely; 95–99%, very likely; >99%, almost certain (Batterham and Hopkins 2006). An 
effect was qualified unclear (not clear, inconclusive) if its confidence interval overlapped 
both thresholds for substantiveness by more than 5%. In the case where the chance that the 
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benefit or detriment is <5% and the chance of the effect being trivial is greater than a 
substantial benefit or detriment, the trivial likelihood is qualified. 
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Results 
Performance 
No clear effect of diet on mean power or fatigue (slope) was observed between the three 
supplemental conditions (Figure 2, Table 1). 
 
Mechanisms Analysis 
For every 1 unit increase in the position of the nausea curve, the position of the mean 
power curve decreased by 0.4 W (90% CI: -3.6–4.4 W; effect unclear). Nausea had no 
detectable influence on sprint mean power when added as a covariate in the polynomial 
analysis (Figure 3).  
 
Substrate Metabolism 
Breath 13C-enrichments during the 3-h background trials are shown in Figure 4. Mean 
peak octanoic-acid oxidation rates at the 180-min sample during the LC-MC and MC-MC 
conditions, respectively, were 0.31 g·min-1 (SDf 32%) and 0.32 g·min-1 (32%). There was 
no clear effect of MCFA adaptation (MC-MC condition) on exogenous octanoic-acid 
oxidation (vs. LC-MC), but interestingly, the oxidation efficiency (ingestion rate/oxidation 
rate) over the period 60-180 min was 98% in the LC-MC condition and 99% in the MC-MC 
condition.  
Overall relative energy contributions are shown in Figure 5. Energy derived from the 
oxidation of endogenous fat was substantially reduced by the oil emulsion (MC-MC: -88; 
59–117%, decrease almost certain; LC-MC -74; -108– -40%, decrease almost certain) 
conditions relative to LC-CHO, but there was no effect of MCFA adaptation evident. There 
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was also a likely reduction (-14%; -29–1%) in energy derived from endogenous-CHO 
oxidation in the LC-MC condition relative to LC-CHO, but the differences between the 
other comparisons were unclear.  
The pattern of substrate oxidation over the 3-h ride is illustrated in Figure 6. The 
increase in the octanoic-acid oxidation rate from the 60th to the 180th min sample points was 
0.09 g·min-1 in the LC-MC condition and 0.10 g·min-1 in the MC-MC condition, but 
consistent with the overall average response, there was no clear difference between 
conditions. Total CHO oxidation rates changed little (<10%) from 60 to 180 min; in 
contrast endogenous fat-oxidation rates declined by 0.04 and 0.11 g·min-1 in the LC-MC 
and MC-MC, respectively, with only a 0.01 g·min-1 decline in the LC-CHO condition. The 
difference in the decline in MC-MC relative to LC-CHO was 3.2-fold (0.7–14). The 
remaining observed between-treatment slope differences for endogenous-fat oxidation were 
inconclusive. 
 
Psychometric Scales 
A statistical summary of gastrointestinal distress (nausea, fullness/bloating, stomach 
cramp, reflux) and exertional parameters (leg soreness, perceived effort) is shown in Table 
2. The responses for nausea, fullness/bloatedness, and perceived effort were selected to 
illustrate the magnitude and temporal effects of treatment and exercise duration (Figure 7). 
3-h ride. The treatment effects on gastrointestinal distress and exertion were similar, but 
the effect of the MC-MC condition relative to LC-CHO on fullness/bloating, stomach 
cramp, and leg soreness were unclear (Table 2). There were no clear consistent patterns in 
slope (increase in scale unit rating) from the 20th min to the 180th min sample points. 
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Performance test. The performance test accentuated the effect of the LC-MC treatment 
on nausea and fullness/bloating, relative to the LC-CHO condition. The exertional 
parameters were also substantially increased in the LC-MC condition but not clearly in the 
MC-MC condition, relative to the LC-CHO control.  The effect of the MC-MC condition 
on gastrointestinal distress markers relative to LC-MC was unclear. There were no clear 
consistent slope patterns from sprints 1 to 10 (not shown). 
 
Plasma, Electrolytes, Acid-base Status, Glucose and Lactate 
No clear differences were observed between conditions for hydrogen ions or standard 
bicarbonate concentrations. Glucose was 5.2% (1.5–8.9%) lower in the MC-MC condition, 
relative to LC-CHO; no clear effect was observed between LC-MC and LC-CHO or LC-
MC and MC-MC conditions. Lactate was 7.9% (1.6–14.2%) lower in the LC-MC 
condition, relative to LC-CHO; no clear effect was observed between MC-MC and LC-
CHO or MC-MC and LC-MC conditions. The outcomes for the remaining electrolyte 
comparisons were qualified as possible increases or decreases (25−75% likelihood) or 
unclear. 
 
Plasma Lipids 
The effects of treatment condition on plasma lipids and octanoic-acid 13C enrichment 
are shown in Figure 8. At rest and during the 3-h steady-state ride plasma triacylglycerol 
concentrations were overall lower by 17% (23– -4%; reduction likely) and 15% (20– -3%; 
reduction likely) in the LC-MC and MC-MC conditions, respectively, relative to LC-CHO; 
there was no clear effect of exercise, however. Plasma glycerol concentrations trended 
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overall lower by 25% (54– -18%) and 45% (84– -17%) in the LC-MC and MC-MC 
conditions, respectively relative to LC-CHO, but the uncertainty meant these effects were 
qualified unclear. At the end of the sprints, there was a 50% lower (137– -6%; likely 
reduction) plasma glycerol concentration. Total plasma free fatty acids were also 27% (73– 
-7%; unclear) and 20% (39–3%; reduction likely) lower in the LC-MC and MC-MC 
conditions, respectively, relative to LC-CHO. There was no effect of MCFA adaptation on 
total and 13C-enriched plasma octanoic-acid concentrations. There were no detectable 
elongation products (13C-enriched fatty acids >8:0) seen in the plasma in either the MC-MC 
or LC-MC condition (data not shown). All remaining comparisons for the respective 
variables were unclear. 
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Discussion 
 
The purpose of this study was to determine if a 2-week high-MCFA dietary adaptation 
period would attenuate gastrointestinal distress, increase octanoic-acid oxidation rate, and 
enhance performance while ingesting a CHO+MCFA-rich oil emulsion during endurance 
cycling in a sample of well-trained female cyclists. The CHO+MCFA-rich oil emulsion 
resulted in mild-to-moderate gastrointestinal distress ratings, relative to the LC-CHO 
condition, and there was no evidence for any attenuation with dietary-MCFA adaptation. 
High amounts of ingested MCFA were oxidized during the 3-h pre-load exercise, and a 
substantial reduction in endogenous fat availability and metabolism was observed with 
MCFA-rich oil emulsion ingestion. However, there was no clear effect of MCFA 
adaptation on octanoic-acid oxidation, ingested 13C-octanoic acid and endogenous 
carbohydrate metabolism, or endurance cycling performance. 
The purpose of the 2-week MCFA-dietary adaptation intervention was to attempt to 
alleviate the gastrointestinal distress normally associated with high MCFA ingestion rates 
during exercise and, therefore, to observe any potential benefit to substrate supply and 
high-intensity endurance performance. In male subjects, we (Thorburn, Vistisen et al. 2006) 
previously observed a clear substantial reduction in gastrointestinal distress parameters with 
MCFA adaptation; and in the covariate analysis, nausea had a moderate-strong reducing 
effect on sprint mean power. Conversely, in the current cohort of female subjects MCFA 
adaptation did not clearly attenuate gastrointestinal distress symptoms, and performance 
was not adversely affected by the intervention relative to the smallest worthwhile detriment 
in mean power (Table 1), or in relation to the distress marker nausea (Figure 3). However, 
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only five female subjects completed the present study leading to modest power and 
contributing to the uncertainty. The confidence limits for mean sprint power suggest that, 
relative to the LC-CHO condition, the true mean population effect of MCFA adaptation 
(MC-MC condition) on performance could be a substantial benefit of up to 2.8%, or an 
impairment in the order of 5.0%; for the control LC-MC condition the true effect could be 
an enhancement of up to 6.6%, or impairment of 10%. This uncertainty in the direction of 
the true population response implicates individual differences in response to the treatment, 
or random error. The sample size required to make a confident statement about whether the 
true population mean effect for the MC-MC vs. LC-CHO comparison is trivial (≤1.1% 
impairment or enhancement) or substantially negative is infinite, because the observed 
effect (1.1% impairment, Table 1) is the same as the smallest worthwhile effect (1.1%), so 
no matter how many subjects are tested, there will be 50% probability that the true 
population mean will be both substantially negative or trivial. For the LC-MC vs LC-CHO 
comparison, however, the sample size to conclude a very likely substantial detriment is 17 
(n required for clear-cut substantial positive or negative effect = (SQRT(width or observed 
CI/width of acceptable CI)) × existing n; source: W. Hopkins, 2006 unpublished). 
Therefore, were we able to have completed testing on all 8 subjects, or extended the cohort 
to 10-12 – a large sample for these types of studies – our conclusions may have been little 
different. 
 
Meanwhile, the finding of an attenuated response to the intervention relative to the male 
cohort studied previously (Thorburn, Vistisen et al. 2006) is consistent with the 
generalization that trained females respond with lower amplitude to nutritional-exercise 
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interventions, relative to their male counterparts. Compared with males, the observed 
average reductions in sprint performance and endogenous-fat oxidation with naïve exposure 
to the MCFA-CHO exercise supplement (LC-CHO condition) were less in magnitude, and 
following MCFA adaptation (MC-MC condition) the attenuating effects of octanoic acid 
and gastrointestinal distress markers were unclear in the females. Other’s have found that 
trained females respond in a lesser magnitude to a number of nutritional interventions 
including recovery in response to high-protein recovery supplements (D.S. Rowlands, 2005 
unpublished), carbohydrate loading, and creatine supplementation (Tarnopolsky 2000). 
 
All previous published work examining the ergogenic potential and metabolic effects of 
MCT-CHO ingestion during exercise has been conducted in well-trained males with the 
outcomes equivocal. In response to naïve exposure, Goedecke et al. (2005) found 
CHO+MCT ingestion to clearly impair performance relative to CHO-only during ~5-h of 
exercise. In their study, the performance of intermediary sprints became increasingly worse, 
and time to complete the final 200-kJ time trial was longer by 13% (90%CL: 8 to 18%) 
with CHO+MCT ingestion. In an earlier study, Goedecke et al. (1999) observed mean 
impairments of 3% and 2.5% in 40-km time-trial performance following a 2-h ride reported 
as statistically insignificant (P-values not provided) when subjects ingested high 
MCT+CHO and low MCT+CHO supplements, respectively, in comparison to CHO-only. 
On the other hand, other authors have reported non-statistically clear (P-value >0.05) trends 
toward performance improvements with CHO+MCT ingestion. Jeukendrup et al. (1998) 
and Vistisen et al. (2003) observed on average 1% and 1.5% improvements in constant 
work or constant time tests, respectively, when subjects ingested a CHO+MCT supplement 
in comparison to CHO-only. The only group reporting a clear performance benefit as a 
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2.5% (90%L: 0.5–4.5) enhancement in 40-km time following a 2-h pre-load was also the 
only group reporting no gastrointestinal distress (Van Zyl, Lambert et al. 1996). This 
finding is in contrast to all of the other studies feeding >30 g of MCT, including our earlier 
adaptation study (Thorburn, Vistisen et al. 2006). Van Zyl et al. (1996) suggested that the 
increase in performance in their study was due to the observed increased availability of 
plasma fatty acids and the subsequent sparing of endogenous carbohydrate (implying 
muscle glycogen). This result contrasts the present findings, as well as that of others 
(Goedecke, Elmer-English et al. 1999; Jeukendrup, Saris et al. 1995; Jeukendrup, Thielen 
et al. 1998; Thorburn, Vistisen et al. 2006) which show that MCT ingestion during exercise 
spares only endogenous fat rather than endogenous carbohydrate utilization. In addition, the 
present study showed a possible reduction in plasma lipid (triacylglycerol, glycerol and 
total fatty acid) availability with MCFA ingestion in comparison to the LC-CHO condition, 
suggesting reduced rather than increased plasma fatty-acid availability (Figure 8). 
 
That there was no clear evidence supporting a performance benefit in this and several 
previous studies might be attributed to the substantial gastrointestinal distress (Jeukendrup, 
Thielen et al. 1998; Goedecke, Elmer-English et al. 1999; Goedecke, Clark et al. 2005; 
Thorburn, Vistisen et al. 2006); indeed we previously provided evidence through 
quantifying the relationship with nausea (Thorburn, Vistisen et al. 2006), though in the 
present study we found no evidence for a relationship between gastrointestinal distress and 
impaired performance. We previously suggested that MCFAs may not even reach the 
systemic circulation as MCFAs, which would exclude utilization of their potentially 
beneficial properties in the muscle cells (Vistisen, Nybo et al. 2003; Thorburn, Vistisen et 
al. 2006). Fatty-acid elongation or storage in the liver prior to release into the circulation, 
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conversion to ketone bodies which were then later oxidized or excreted through the urine or 
breath, or malabsorption by the gut and excretion in the feces we proposed as possible 
fates. However, several observations in the present study suggest that the muscle was the 
more likely site for MCFA disposal during exercise: we observed 13C-octanoic acid in the 
plasma and the oxidation rates were rapid and exclusive; there were no measured 
elongation products; and the average energy provided by octanoic-acid oxidation was 
approximately matched by the reduction in energy provided from endogenous-fat oxidation 
(Figure 5).  
 
Although we can not be certain that all of the ingested MCFAs were metabolised by the 
exercising muscle, we did make some further interesting and novel observations pertaining 
to the CHO+MCFA-rich esterified oil emulsion. In males, we found a high efficiency of 
octanoic-acid oxidation of up to ~100% ingestion rate (0.43 g·min-1, 5.3 mg·kg-1·min-1) 
when co-ingested with CHO (Thorburn, Vistisen et al. 2006). In the present study the 
maximum octanoic-acid oxidation rate reached in the 180th minute of the 3-h ride was 
similar (4.9 mg·kg-1·min-1), which also approximated the MCFA ingestion rate (Figure 6). 
These oxidation rates are 2-3 fold higher than previously reported (0.15 g·min-1, 
(Jeukendrup, Saris et al. 1996) and suggest a unique quality of the exercise supplements 
promoting high absorption and oxidation rates. Fat digestion is normally slow because 
triacylglycerols aggregate into large droplets in the small intestine, slowing the action of 
pancreatic lipase. However, our supplements were suspended in an emulsion, which 
distributes lipids into smaller droplets, thereby increasing their accessibility to pancreatic 
lipase. Also, cyclists were fed MCFAs and long chain fatty acids in the form of structured 
triacylglycerols, which may have enhanced MCFA absorption due to the increase in 
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pancreatic secretion which is stimulated by long-chain triglyceride, but not MCT ingestion 
(Mott, Sarles et al. 1972). Therefore, more extensive hydrolysis of the structured 
triacylglycerols may have occurred in comparison to MCT solution/suspensions used in 
previous MCFA-oxidation rate studies (Jeukendrup, Saris et al. 1996), leading to greater 
absorption, blood concentrations, and mitochondrial oxidation. Despite the higher oxidation 
rates, there was little evidence for an effect of MCFA adaptation on absorption or metabolic 
clearance rates based on the observation of similar plasma 13C-enriched octanoic-acid 
concentrations, relative to the LC-MC control.  
 
In summary, the ingestion of a CHO+MCFA-rich esterified oil emulsion resulted in high 
efficiency of exogenous MCFA oxidation, but induced mild-moderate gastric distress 
symptoms during prolonged exercise in female cyclists. Two weeks’ adaptation to a 
MCFA-rich diet did not attenuate the gastrointestinal distress symptoms, and no clear 
performance benefit was observed with ingestion of the CHO+MCFA-rich exercise 
supplement or following adaptation. Similar to the consensus from previous adaptation and 
naïve exposure studies in males, there was little evidence to suggest that increasing 
exogenous energy supply through the addition of MCFAs to the training diet or exercise 
supplements will result in ergogenic outcomes in trained female cyclists. While some 
uncertainty remains, the results of our investigations lead to the conclusion that further 
investigation of MCFA ingestion as a potential ergogenic aid for exercise performance is 
not warranted. 
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Tables 
 
Table 1.  Comparison of the three dietary conditions on performance.   
 Effect Comparisons (%) ±90% CLa and Qualitative Inference 
PERFORMANCE 
MEASURE 
MC-MC minus 
LC-CHO 
LC-MC minus  
LC-CHO 
MC-MC minus 
LC-MC 
 
Sprints 1-9    
Mean Powerb -1.1 ±3.9 
Unclear 
-1.9 ±8.5 
Unclear 
0.9 ±9.5 
Unclear 
Fatiguec -0.9 ±6.4 
 Unclear 
-0.4 ±5.3 
Unclear 
0.4 ±6.1 
Unclear  
Sprint 10    
Mean Power -2.2 ±6.7 
Unclear 
-2.8 ±9.2 
Unclear 
0.6 ±9.6 
 Unclear 
a±90%CL: add and subtract this number to the mean effect to obtain the 90% 
confidence limits for the true difference. 
bMean power is the overall mean power effect for sprints 1-9. The sprint 10 effect 
was excluded in the linear model because is approached differently by the subjects; 
it was extracted separately from the repeated-measures model. 
cFatigue is the percentage difference between the conditions in the linear decline in 
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power evaluated between sprints 1 and 9. Analysis is based on the reduction in 
mean power per sprint. More negative means greater relative fatigue. 
Abbreviations: MCFA-rich esterified oil diet with the CHO+MCFA-rich oil 
emulsion ingested during exercise (MC-MC); long-chain fatty-acid rich diet with 
the CHO+MCFA-rich esterified oil emulsion ingested during exercise (LC-MC); 
long-chain fatty-acid rich diet with a CHO-only during exercise (LC-CHO). 
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Table 2.  Summary of the overall effect of the three dietary conditions on gastrointestinal distress and exertional parameters during the 
3-h ride and performance test.   
 Mean Effect Comparisonsa ±90% CLb and Qualitative Inference 
 3-h Ride  Performance Test 
PARAMETER MC-MC 
minus 
LC-CHO 
LC-MC minus 
LC-CHO 
MC-MC 
minus 
LC-MC 
 MC-MC minus 
LC-CHO 
LC-MC minus 
LC-CHO 
MC-MC 
minus 
LC-MC 
        
Nausea 0.8 ±0.5 
Increase very 
likely 
0.4 ±0.5 
Increase 
possible 
0.4 ±0.8 
Unclear 
 2.5 ±0.7 
Increase almost 
certain 
2.1 ±0.5 
Increase almost 
certain 
0.3 ±0.6 
Increase 
unlikely 
Fullness / 
Bloating 
1.9 ±2.6 
Unclear 
1.6 ±0.2 
Increase 
0.4 ±3.1 
Unclear 
 3.5 ±1.9 
Increase very likely 
2.7 ±0.4 
Increase almost 
0.8 ±2.7 
Unclear 
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almost certain certain 
Stomach 
Cramp 
0.6 ±1.4 
Unclear 
0.3 ±0.2 
Increase likely 
0.4 ±1.6 
Unclear 
 0.6 ±1.8 
Unclear 
0.9 ±1.5 
Unclear 
-0.2 ±2.4 
Unclear 
Reflux 1.8 ±1.3 
Increase very 
likely 
1.7 ±0.2 
Increase 
almost certain 
0.0 ±1.6 
Unclear 
 2.6 ±0.4 
Increase almost 
certain 
3.3 ±0.5 
Increase almost 
certain 
-0.6 ±0.9 
Decrease 
possible 
Leg Soreness 0.1 ±0.4 
Unclear 
0.2 ±0.3 
Increase 
possible 
-0.1 ±0.3 
Decrease 
unlikely 
 0.4 ±1.7 
Unclear 
1.9 ±0.5 
Increase almost 
certain 
-1.5 ±1.6 
Decrease 
likely 
Perceived 
Effort 
0.3 ±0.2 
Increase likely 
0.1 ±0.2 
Increase 
possible 
0.2 ±0.2 
Increase 
possible 
 0.8 ±1.3 
Increase possible 
1.3 ±0.6 
Increase very likely 
-0.5 ±1.3 
Unclear 
aMean effect comparisons are presented in Likert Scale Units 
b±90%CL: add and subtract this number to the mean effect to obtain the 90% confidence limits for the true difference. 
Abbreviations: MCFA-rich esterified oil diet with the CHO+MCFA-rich oil emulsion ingested during exercise (MC-MC); long-chain 
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fatty-acid rich diet with the CHO+MCFA-rich esterified oil emulsion ingested during exercise (LC-MC); long-chain fatty-acid rich diet 
with a CHO-only during exercise (LC-CHO). 
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Figure Captions 
 
Figure 1. Study Design. Three 2-week dietary adaptation periods including a 13C 
background breath-enrichment trial on day 11 and performance test on day 14 with 
ingestion of either the CHO+MCFA-rich esterified oil emulsion or placebo CHO-only 
exercise supplement. 
 
Figure 2. Sprint mean power in the performance tests. Data are back log-transformed least 
squares means. Bars are between-subject SDf, those marked with an × represent the within-
subject deviation. Y-axes are presented on logarithmic scales. 
 
Figure 3. Effect of covariate nausea on mean sprint power (y-axis position coefficient) 
derived from the within-subject polynomial analysis. Data points are the observed mean 
effect of treatment relative to the reference condition and bars are 90% confidence 
intervals. The proportion of the confidence interval with beneficial, trivial or detrimental 
population outcomes is defined and the practical inference of the observed outcome 
qualified on the right.  
 
Figure 4. Breath 13C-enrichment. Data are raw means ± between-subject SD. 
 
Figure 5.  Mean substrate oxidation as percentage contribution to total energy expenditure 
during the 3-h rides. 
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Figure 6. Pattern of substrate oxidation during the 3-h rides. Data are back-log transformed 
least-squares means. Bars are between-subject SDf, those marked with an × represent the 
within-subject deviation. Y-axes are presented on logarithmic scales. 
 
Figure 7. Exertional parameters and gastrointestinal distress ratings during the 3-h and 
performance tests. Ratings are least-squares means ± between-subject SD. SD bars marked 
with an × represent the within-subject deviation. 
 
Figure 8.  Effect of treatment on plasma lipid concentration during exercise. Octanoic acid 
closed symbols = total octanoic acid; open symbols = 13C-enriched octanoic acid. Bars are 
between-subject SDf. SD bars marked with an × represent the within-subject deviation. Y-
axes are presented on logarithmic scales. 
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